Literature DB >> 8057202

In-vitro photocytotoxicity of lysosomotropic immunoliposomes containing pheophorbide a with human bladder carcinoma cells.

L C Bergstrom1, I Vucenik, I K Hagen, S A Chernomorsky, R D Poretz.   

Abstract

Pheophorbide a is a photocytotoxic agent. To develop a tissue-specific, intracellularly targeted photoactive system, pheophorbide a was incorporated into immunoliposomes coated with a monoclonal antibody (T-43) directed against the T-24 bladder tumor cell line. The efficacy of this system was studied in vitro using the human bladder tumor cell line MGH-U1. Uptake and localization were determined by the fluorescence of the immunoliposome markers within biochemically resolved subcellular components. The results demonstrate localization of the immunoliposome markers within the lysosomes of the tumor cells. Specific monoclonal antibody enhancement of the immunoliposomes uptake by MGH-U1 cells was demonstrated by the use of soluble T-43 monoclonal antibody as a competitive inhibitor. Pheophorbide-a-loaded immunoliposomes were shown to be photocytotoxic towards MGH-U1 cells at concentrations equivalent to photosensitizer at 500 ng ml-1. Treated cells, when protected from light, showed no cytotoxicity. These results demonstrate that uptake of pheophorbide-a-containing immunoliposomes by target cells and subsequent delivery to the lysosomes cause photoactivated killing of tumor cells. The utilization of immunoliposomes for intracellular lysosomal targeting of photoactive drugs to tumor cells constitutes a potentially valuable approach to photodynamic therapeutics.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8057202     DOI: 10.1016/1011-1344(94)07008-3

Source DB:  PubMed          Journal:  J Photochem Photobiol B        ISSN: 1011-1344            Impact factor:   6.252


  8 in total

1.  Can nanotechnology potentiate photodynamic therapy?

Authors:  Ying-Ying Huang; Sulbha K Sharma; Tianhong Dai; Hoon Chung; Anastasia Yaroslavsky; Maria Garcia-Diaz; Julie Chang; Long Y Chiang; Michael R Hamblin
Journal:  Nanotechnol Rev       Date:  2012-03       Impact factor: 7.848

Review 2.  Photonanomedicine: a convergence of photodynamic therapy and nanotechnology.

Authors:  Girgis Obaid; Mans Broekgaarden; Anne-Laure Bulin; Huang-Chiao Huang; Jerrin Kuriakose; Joyce Liu; Tayyaba Hasan
Journal:  Nanoscale       Date:  2016-06-20       Impact factor: 7.790

Review 3.  Recent strategies towards the surface modification of liposomes: an innovative approach for different clinical applications.

Authors:  Amjad Ali Khan; Khaled S Allemailem; Saleh A Almatroodi; Ahmed Almatroudi; Arshad Husain Rahmani
Journal:  3 Biotech       Date:  2020-03-10       Impact factor: 2.406

4.  Impacting Pancreatic Cancer Therapy in Heterotypic in Vitro Organoids and in Vivo Tumors with Specificity-Tuned, NIR-Activable Photoimmunonanoconjugates: Towards Conquering Desmoplasia?

Authors:  Girgis Obaid; Shazia Bano; Srivalleesha Mallidi; Mans Broekgaarden; Jerrin Kuriakose; Zachary Silber; Anne-Laure Bulin; Yucheng Wang; Zhiming Mai; Wendong Jin; Diane Simeone; Tayyaba Hasan
Journal:  Nano Lett       Date:  2019-10-04       Impact factor: 11.189

Review 5.  Some Natural Photosensitizers and Their Medicinal Properties for Use in Photodynamic Therapy.

Authors:  Tomasz Piotr Kubrak; Przemysław Kołodziej; Jan Sawicki; Anna Mazur; Katarzyna Koziorowska; David Aebisher
Journal:  Molecules       Date:  2022-02-10       Impact factor: 4.411

Review 6.  Shining light on nanotechnology to help repair and regeneration.

Authors:  Asheesh Gupta; Pinar Avci; Magesh Sadasivam; Rakkiyappan Chandran; Nivaldo Parizotto; Daniela Vecchio; Wanessa C M A de Melo; Tianhong Dai; Long Y Chiang; Michael R Hamblin
Journal:  Biotechnol Adv       Date:  2012-08-21       Impact factor: 14.227

7.  Engineering Remotely Triggered Liposomes to Target Triple Negative Breast Cancer.

Authors:  Alexandra Sneider; Rahul Jadia; Brandon Piel; Derek VanDyke; Christopher Tsiros; Prakash Rai
Journal:  Oncomedicine       Date:  2017-01-01

Review 8.  Photosensitizers in prostate cancer therapy.

Authors:  Taher Gheewala; Troy Skwor; Gnanasekar Munirathinam
Journal:  Oncotarget       Date:  2017-05-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.